Health & Medicine

• Health & Medicine
• Policy & Insight

Cancer Research UK report highlights stark cancer inequalities across Scotland

A landmark report on deprivation and cancer launched at the Scottish Cancer Conference today shows that the burden of cancer is not felt equally across Scotland.  A landmark report on deprivation and cancer launched at the Scottish Cancer Conference today shows that the burden of cancer is not felt equally across Scotland. 

28 November 2022

• Health & Medicine

First-of-its-kind app for patients on clinical trials being piloted by Cancer Research UK

Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.   Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.  

28 November 2022

• Health & Medicine

Why do non-smokers face delays in getting a lung cancer diagnosis?

Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer

25 November 2022

• Health & Medicine
• Policy & Insight

How targeted screening can help the NHS save lives from lung cancer, the UK's leading cause of cancer death

Finding lung cancer early makes it much easier to treat. Dr Samantha Quaife, an expert in lung screening, explains how it can save lives and fight inequality. Finding lung cancer early makes it much easier to treat. Dr Samantha Quaife, an expert in lung screening, explains how it can save lives and fight inequality.

23 November 2022

• Health & Medicine

Into the archives: the story of HPV and cervical cancer

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

21 November 2022

• Health & Medicine
• Policy & Insight

'Scandinavian quality and Singaporean efficiency': what the autumn statement means for cancer

With budgets being squeezed by inflation, Jeremy Hunt announced measures to increase tax intakes and put a lid on public spending. But what does it mean for people affected by cancer?  With budgets being squeezed by inflation, Jeremy Hunt announced measures to increase tax intakes and put a lid on public spending. But what does it mean for people affected by cancer? 

17 November 2022

• Health & Medicine

NICE recommends pembrolizumab for 1,600 more people with breast cancer

The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales. The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

14 November 2022

• Science & Technology
• Health & Medicine

Repurposing radiotherapy drugs could give immunotherapy a boost

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

11 November 2022

• Health & Medicine

The rise of the ‘long-waiter’ – why cancer waiting times are showing the pressure more than ever before

10 November 2022

• Science & Technology
• Health & Medicine

Changes to chromosomes impact how children's brain tumours respond to treatment

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

4 November 2022

• Health & Medicine

6 highlights from our Black in Cancer conference

Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start. Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start.

31 October 2022